| Primary |
| Hiv Infection |
70.8% |
| Product Used For Unknown Indication |
6.5% |
| Drug Use For Unknown Indication |
5.1% |
| Drug Exposure During Pregnancy |
3.3% |
| Foetal Exposure During Pregnancy |
2.0% |
| Antiviral Treatment |
1.9% |
| Hypertension |
1.4% |
| Depression |
1.2% |
| Ill-defined Disorder |
1.2% |
| Plasma Cell Myeloma |
1.0% |
| Pneumocystis Jiroveci Pneumonia |
0.9% |
| Tuberculosis |
0.7% |
| Anxiety |
0.6% |
| Oral Candidiasis |
0.6% |
| Antibiotic Prophylaxis |
0.5% |
| Gastrooesophageal Reflux Disease |
0.5% |
| Antifungal Prophylaxis |
0.4% |
| Antiretroviral Therapy |
0.4% |
| Cough |
0.4% |
| Hyperlipidaemia |
0.4% |
|
| Premature Baby |
8.5% |
| Renal Failure Acute |
8.5% |
| Toxic Epidermal Necrolysis |
6.6% |
| Toxicity To Various Agents |
6.6% |
| Weight Decreased |
6.6% |
| Death |
5.7% |
| Oedema Peripheral |
5.7% |
| Ventricular Hypertrophy |
5.7% |
| Myocardial Infarction |
4.7% |
| Nephrolithiasis |
4.7% |
| Premature Labour |
4.7% |
| Thrombocytopenia |
4.7% |
| Epistaxis |
3.8% |
| Hepatitis B |
3.8% |
| Pyrexia |
3.8% |
| Rash |
3.8% |
| Tachycardia |
3.8% |
| Depression |
2.8% |
| Drug Interaction |
2.8% |
| Exposure During Pregnancy |
2.8% |
|
| Secondary |
| Hiv Infection |
62.3% |
| Product Used For Unknown Indication |
10.6% |
| Drug Use For Unknown Indication |
9.7% |
| Drug Exposure During Pregnancy |
5.4% |
| Antiretroviral Therapy |
2.3% |
| Antiviral Treatment |
1.8% |
| Tuberculosis |
1.4% |
| Pathogen Resistance |
1.0% |
| Acquired Immunodeficiency Syndrome |
0.7% |
| Antifungal Prophylaxis |
0.6% |
| Prophylaxis |
0.6% |
| Hiv Test Positive |
0.5% |
| Hypertension |
0.5% |
| Antibiotic Prophylaxis |
0.5% |
| Opportunistic Infection Prophylaxis |
0.4% |
| Oral Candidiasis |
0.4% |
| Diarrhoea |
0.4% |
| Depression |
0.3% |
| Pneumocystis Jiroveci Pneumonia |
0.3% |
| Fungal Infection |
0.3% |
|
| Progressive External Ophthalmoplegia |
13.4% |
| Ventricular Hypertrophy |
10.6% |
| Vomiting |
8.2% |
| Abortion Spontaneous |
7.4% |
| Rhabdomyolysis |
7.1% |
| Weight Decreased |
7.1% |
| Drug Exposure During Pregnancy |
4.9% |
| Renal Failure Acute |
4.1% |
| Thrombocytopenia |
4.1% |
| Respiratory Failure |
3.8% |
| Umbilical Cord Abnormality |
3.5% |
| Premature Baby |
3.3% |
| Diffuse Large B-cell Lymphoma |
3.0% |
| Gastrointestinal Malformation |
3.0% |
| Osteonecrosis |
3.0% |
| Death |
2.7% |
| Hypokalaemia |
2.7% |
| Myocardial Infarction |
2.7% |
| Rash Generalised |
2.7% |
| Stevens-johnson Syndrome |
2.7% |
|
| Concomitant |
| Hiv Infection |
65.9% |
| Product Used For Unknown Indication |
6.5% |
| Antiretroviral Therapy |
4.4% |
| Drug Use For Unknown Indication |
3.8% |
| Drug Exposure During Pregnancy |
3.4% |
| Prophylaxis |
2.8% |
| Pneumocystis Jiroveci Pneumonia |
1.8% |
| Hypertension |
1.5% |
| Tuberculosis |
1.2% |
| Depression |
1.0% |
| Acquired Immunodeficiency Syndrome |
1.0% |
| Asthma |
0.9% |
| Hiv Test Positive |
0.9% |
| Prophylaxis Against Hiv Infection |
0.8% |
| Pulmonary Tuberculosis |
0.8% |
| Hodgkin's Disease |
0.8% |
| Opportunistic Infection Prophylaxis |
0.7% |
| Diabetes Mellitus |
0.7% |
| Maternal Therapy To Enhance Foetal Lung Maturity |
0.6% |
| Anaemia |
0.6% |
|
| Asthmatic Crisis |
6.9% |
| Myocardial Infarction |
6.5% |
| Abortion Spontaneous |
6.1% |
| Oesophageal Candidiasis |
6.1% |
| Premature Labour |
6.1% |
| Small For Dates Baby |
6.1% |
| Sepsis |
5.6% |
| Hyperbilirubinaemia Neonatal |
5.2% |
| Rash |
5.2% |
| Renal Tubular Necrosis |
5.2% |
| Drug Exposure During Pregnancy |
4.8% |
| Pancytopenia |
4.8% |
| Pneumonia |
4.8% |
| Thrombocytopenia |
4.8% |
| Vomiting |
4.3% |
| Sinus Bradycardia |
3.9% |
| Colon Cancer |
3.5% |
| Convulsion |
3.5% |
| Drug Interaction |
3.5% |
| Renal Failure Acute |
3.5% |
|
| Interacting |
| Hiv Infection |
45.8% |
| Product Used For Unknown Indication |
31.9% |
| Anxiety |
3.6% |
| Depression |
3.6% |
| Renal Transplant |
3.6% |
| Drug Use For Unknown Indication |
3.0% |
| Immunosuppression |
1.8% |
| Asthma |
1.2% |
| Hiv Test Positive |
1.2% |
| Blood Pressure Increased |
0.6% |
| Erectile Dysfunction |
0.6% |
| Herpes Simplex |
0.6% |
| Immunosuppressant Drug Therapy |
0.6% |
| Intervertebral Disc Protrusion |
0.6% |
| Pulmonary Embolism |
0.6% |
| Splenectomy |
0.6% |
|
| Drug Interaction |
13.6% |
| Vision Blurred |
13.6% |
| White Blood Cell Count Increased |
13.6% |
| Gastrointestinal Carcinoma |
9.1% |
| Myocardial Infarction |
9.1% |
| Toxicity To Various Agents |
9.1% |
| Hepatic Failure |
4.5% |
| Oedema Peripheral |
4.5% |
| Off Label Use |
4.5% |
| Potentiating Drug Interaction |
4.5% |
| Puncture Site Haemorrhage |
4.5% |
| Rash Maculo-papular |
4.5% |
| Visual Acuity Reduced |
4.5% |
|
